PDF(Pubmed)
Abstract：
BACKGROUND: Chronic disease self-management (CDSM) is a vital component of congestive heart failure (CHF) programmes. Recent CHF guidelines have downgraded CDSM programmes citing a lack of gold-standard evidence. This protocol describes the aims and methods of a systematic review to collate and synthesise the published research evidence to determine the effectiveness of CDSM programmes and interventions for patients treated for CHF.
METHODS: Medline, PubMed, Embase, CENTRAL, CINAHL, Cochrane Central Register of Controlled Trials, PsycINFO, SCOPUS, Web of Science, the Science Citation Index and registers of clinical trials will be searched from 1966 to 2024. In addition, the reference lists of shortlisted articles will be reviewed. Randomised controlled trials, with case management interventions of CDSM and CHF with reported major adverse cardiovascular events (MACEs), will be extracted and analysed. There is no restriction on language. Study protocol template developed from Cochrane Collaboration and Reporting adheres to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guidelines for systematic review and meta-analyses 2020. Two independent authors will apply inclusions and exclusion criteria to limit article search and assess bias and certainty of evidence rating. Data extraction and study description of included studies will include quality appraisal of studies and quantitative synthesis of data will then be undertaken to ascertain evidence for the study aims. Subgroup analyses will be conducted for different CDSM programmes. The primary outcome will be a significant change in MACE parameters between intervention and control arms. Meta-analysis will be conducted using statistical software, if feasible.
BACKGROUND: Ethics approval is not sought as the study is not collecting primary patient data. The results of this study will be disseminated through peer-reviewed scientific journals and also presented to audiences through meetings and scientific conferences.
UNASSIGNED: CRD42023431539.
METHODS: Medline, PubMed, Embase, CENTRAL, CINAHL, Cochrane Central Register of Controlled Trials, PsycINFO, SCOPUS, Web of Science, the Science Citation Index and registers of clinical trials will be searched from 1966 to 2024. In addition, the reference lists of shortlisted articles will be reviewed. Randomised controlled trials, with case management interventions of CDSM and CHF with reported major adverse cardiovascular events (MACEs), will be extracted and analysed. There is no restriction on language. Study protocol template developed from Cochrane Collaboration and Reporting adheres to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guidelines for systematic review and meta-analyses 2020. Two independent authors will apply inclusions and exclusion criteria to limit article search and assess bias and certainty of evidence rating. Data extraction and study description of included studies will include quality appraisal of studies and quantitative synthesis of data will then be undertaken to ascertain evidence for the study aims. Subgroup analyses will be conducted for different CDSM programmes. The primary outcome will be a significant change in MACE parameters between intervention and control arms. Meta-analysis will be conducted using statistical software, if feasible.
BACKGROUND: Ethics approval is not sought as the study is not collecting primary patient data. The results of this study will be disseminated through peer-reviewed scientific journals and also presented to audiences through meetings and scientific conferences.
UNASSIGNED: CRD42023431539.
摘要：
背景：慢性疾病自我管理（CDSM）是充血性心力衰竭（CHF）计划的重要组成部分。最近的CHF指南以缺乏黄金标准证据为由下调了CDSM计划的评级。该协议描述了系统评价的目的和方法，以整理和综合已发表的研究证据，以确定CDSM计划和干预措施对CHF治疗患者的有效性。
方法：Medline，PubMed,Embase,中部,CINAHL,Cochrane中央控制试验登记册,PsycINFO,Scopus,WebofScience,科学引文索引和临床试验注册将从1966年到2024年进行搜索。此外,将审查入围文章的参考列表。随机对照试验,采用CDSM和CHF的病例管理干预措施，报告主要不良心血管事件（MACE），将被提取和分析。语言没有限制。从Cochrane协作和报告开发的研究方案模板符合系统审查和荟萃分析的首选报告项目2020年系统审查和荟萃分析方案指南。两名独立作者将应用纳入和排除标准来限制文章搜索并评估证据评级的偏见和确定性。纳入研究的数据提取和研究描述将包括研究的质量评估，然后将进行数据的定量综合，以确定研究目标的证据。将对不同的CDSM计划进行亚组分析。主要结果将是干预和控制组之间MACE参数的显着变化。Meta分析将使用统计软件进行，如果可行的话。
背景：由于本研究未收集主要患者数据，因此不寻求伦理批准。这项研究的结果将通过同行评审的科学期刊传播，并通过会议和科学会议向听众介绍。
■CRD42023431539。
方法：Medline，PubMed,Embase,中部,CINAHL,Cochrane中央控制试验登记册,PsycINFO,Scopus,WebofScience,科学引文索引和临床试验注册将从1966年到2024年进行搜索。此外,将审查入围文章的参考列表。随机对照试验,采用CDSM和CHF的病例管理干预措施，报告主要不良心血管事件（MACE），将被提取和分析。语言没有限制。从Cochrane协作和报告开发的研究方案模板符合系统审查和荟萃分析的首选报告项目2020年系统审查和荟萃分析方案指南。两名独立作者将应用纳入和排除标准来限制文章搜索并评估证据评级的偏见和确定性。纳入研究的数据提取和研究描述将包括研究的质量评估，然后将进行数据的定量综合，以确定研究目标的证据。将对不同的CDSM计划进行亚组分析。主要结果将是干预和控制组之间MACE参数的显着变化。Meta分析将使用统计软件进行，如果可行的话。
背景：由于本研究未收集主要患者数据，因此不寻求伦理批准。这项研究的结果将通过同行评审的科学期刊传播，并通过会议和科学会议向听众介绍。
■CRD42023431539。
